J A Overbeek
Overview
Explore the profile of J A Overbeek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Bruin I, Klop C, Wyers C, Overbeek J, Geusens P, van den Bergh J, et al.
Osteoporos Int
. 2019 Feb;
30(3):573-581.
PMID: 30737577
Introduction: It remains unclear to what extent use of antidepressants and benzodiazepines is associated with mortality risk after a major osteoporotic fracture (MOF). We aimed to study the cumulative use...
2.
van de Ven L, Klop C, Overbeek J, de Vries F, Burden A, Janssen P
Osteoporos Int
. 2018 Aug;
29(11):2477-2485.
PMID: 30112636
Introduction: We evaluated the association between the use of antidepressants or benzodiazepines and the risk of a subsequent major osteoporotic fracture. Methods: A cohort study was performed using the Dutch...
3.
Houben E, van Haalen H, Sparreboom W, Overbeek J, Ezendam N, Pijnenborg J, et al.
Med Oncol
. 2017 Feb;
34(4):50.
PMID: 28224447
Information on treatment patterns for ovarian cancer (OC) is limited. The aim of this study was to describe current patterns of chemotherapy and other systemic treatments for OC in the...
4.
Overbeek J, van der Heijden A, Herings R, Nijpels G
Ned Tijdschr Geneeskd
. 2017 Jan;
160:D673.
PMID: 28098041
Objective: To study the trend in the prevalence of diabetes in the Netherlands during the period 1999-2014. Design: Descriptive study of prevalence. Methods: The prevalence of diabetes during the period...
5.
Houben E, van Haalen H, Sparreboom W, Overbeek J, Ezendam N, Pijnenborg H, et al.
Value Health
. 2016 May;
17(7):A655.
PMID: 27202372
No abstract available.
6.
Van den Berg E, Overbeek J, Penning-van Beest F, Khalid J, Dekhuijzen P, Herings R
Value Health
. 2016 May;
17(7):A590.
PMID: 27202015
No abstract available.
7.
Heintjes E, Overbeek J, Blin P, Hall G, Lapi F, Prieto A, et al.
Value Health
. 2016 May;
17(7):A359.
PMID: 27200724
No abstract available.
8.
Overbeek J, Penning F, van Dongen E, Herings R
Value Health
. 2016 May;
17(7):A337.
PMID: 27200604
No abstract available.
9.
Klop C, Welsing P, Elders P, Overbeek J, Souverein P, Burden A, et al.
Osteoporos Int
. 2015 Mar;
26(6):1831-40.
PMID: 25822104
Unlabelled: Long-term persistence with anti-osteoporosis drugs and determinants for discontinuation among fracture patients were examined. Persistence was 75.0 and 45.3 % after 1 and 5 years, respectively. Those aged ≥80...
10.
Fazeli Farsani S, Souverein P, Overbeek J, van der Vorst M, Knibbe C, Herings R, et al.
Br J Clin Pharmacol
. 2015 Feb;
80(2):294-303.
PMID: 25683632
Aim: The aim of the study was to document long term trends in oral antidiabetic drug (OAD) use among children and adolescents in the Netherlands. Methods: A population-based cohort study...